GlobeNewswire Inc.·1d ago·NaInventiva to Report 2025 Results as MASH Drug Candidate AdvancesInventiva will release 2025 financial results March 30, 2026, while advancing lanifibranor in Phase 3 MASH trials. IVAPhase 3 clinical trialfinancial results
GlobeNewswire Inc.··Na